Andrew S Chi Selected Research

Andrew S Chi Research Topics

Disease

27	Glioblastoma (Glioblastoma Multiforme) 12/2020 - 07/2009
26	Neoplasms (Cancer) 01/2020 - 07/2009
23	Glioma (Gliomas) 02/2021 - 04/2007
4	Oligodendroglioma 02/2021 - 06/2013
3	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 06/2013
2	Brain Neoplasms (Brain Tumor) 02/2021 - 11/2014
2	Neoplasm Metastasis (Metastasis) 02/2016 - 02/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2016 - 02/2015
1	Lymphoma (Lymphomas) 12/2020
1	Diffuse Intrinsic Pontine Glioma 04/2019
1	Exanthema (Rash) 01/2019
1	Fatigue 01/2019
1	Gastritis 01/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Hyperglycemia 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Edema (Dropsy) 11/2018
1	Adenocarcinoma of Lung 11/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Meningeal Carcinomatosis 02/2016
1	Necrosis 07/2015
1	Hypoxia (Hypoxemia) 07/2015

Drug/Important Bio-Agent (IBA)

12	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 06/2013
9	Biomarkers (Surrogate Marker)IBA 10/2017 - 06/2013
8	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 10/2015
5	alpha-hydroxyglutarateIBA 01/2018 - 12/2015
4	Pharmaceutical PreparationsIBA 12/2020 - 01/2018
4	TIC10 compoundIBA 10/2019 - 01/2017
4	Bevacizumab (Avastin)FDA Link 04/2019 - 01/2013
4	EnzymesIBA 01/2019 - 04/2007
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 11/2013
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 10/2017
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2015
3	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2014
2	Biological ProductsIBA 01/2021 - 11/2018
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2020 - 01/2018
2	dacomitinibIBA 01/2020 - 01/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 10/2017
2	MethyltransferasesIBA 01/2019 - 01/2018
2	iniparibIBA 01/2019 - 10/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 01/2019
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2018 - 12/2015
2	Coenzymes (Enzyme Cofactors)IBA 01/2017 - 12/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 01/2017
2	cediranib (AZD2171)IBA 01/2017 - 11/2013
2	Anaplastic Lymphoma KinaseIBA 02/2016 - 02/2015
2	alectinibIBA 02/2016 - 02/2015
1	Lomustine (CCNU)FDA Link 02/2021
1	Vincristine (Oncovin)FDA LinkGeneric 02/2021
1	Procarbazine (Matulane)FDA Link 02/2021
1	HexokinaseIBA 12/2020
1	epidermal growth factor receptor VIIIIBA 01/2020
1	dipinacoline glutamateIBA 10/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 04/2019
1	Histones (Histone)IBA 04/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2019
1	AntigensIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	rovalpituzumab tesirineIBA 01/2019
1	NVP-BKM120IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	LigandsIBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	O-(6)-methylguanineIBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2017
1	osimertinibIBA 11/2017
1	ProlactinIBA 10/2017
1	CreatineIBA 01/2017
1	tivozanibIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Choline (Choline Chloride)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 09/2016
1	TransferasesIBA 09/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2016
1	NAD (NADH)IBA 09/2016
1	Niacinamide (Nicotinamide)FDA LinkGeneric 09/2016
1	nicotinate phosphoribosyltransferaseIBA 12/2015
1	ProdrugsIBA 10/2015
1	Messenger RNA (mRNA)IBA 07/2015
1	Ouabain (G Strophanthin)IBA 07/2015
1	Digoxin (Digitek)FDA LinkGeneric 07/2015
1	PanobinostatIBA 06/2015
1	Histone Deacetylase InhibitorsIBA 06/2015
1	Antineoplastic Agents (Antineoplastics)IBA 06/2015

Therapy/Procedure

22	Therapeutics 01/2020 - 09/2006
8	Drug Therapy (Chemotherapy) 02/2021 - 06/2013
4	Radiotherapy 04/2019 - 08/2013
2	Precision Medicine 01/2018 - 04/2016
2	Aftercare (After-Treatment) 01/2017 - 01/2012
1	Immunotherapy 10/2020
1	Transplantation 01/2019
1	Heterologous Transplantation (Xenotransplantation) 07/2015
1	Drug Tapering 02/2015